Document Type : Original Article


Department of Biology, School of Basic Sciences, Hamedan Branch, Islamic Azad University, Hamedan, Iran


Introduction and Aim: Fibroblastoma is a common skin malignancy and a common cause of morbidity worldwide. Studies have shown that sex steroid hormones including progesterone have cytotoxic effects on cancer cells. According to this, the present study aims to determine the effects of progesterone cytotoxic concentration on iNOs expression in fibroblastoma (L929) cells.
Methods: Cell viability was measured using MTT assay in cells exposed to 0.001, 0.01, 0.1, 1, and 10 mg/ml of progesterone, and IC50 dose was determined. NO concentration levels were also measured using the Griess test. The expression level of iNOS was measured by real-time RT-PCR. Data were analyzed using SPSS by one-way ANOVA.
Results: Viability significantly decreased in fibroblastoma cells exposed to 1 and 10 mg/ml of progesterone (P<0.001). The relative expression level of iNOS significantly increased in cells exposed to IC50 dose of progesterone (P<0.001). The relative concentration of NO significantly increased in fibroblastoma cells exposed to 0.01, 0.1, and 1 mg/ml of progesterone (P<0.001, P<0.001, and P<0.05, respectively).
Conclusion: Progesterone has cytotoxic effects on fibroblastoma cancer cells due partly to the effects of the hormone on iNOS expression level and increased NO that probably induces apoptosis in fibroblastoma cancer cells.


Main Subjects

Armitage, J.D., Newnes, H.V., McDonnell, A., Bosco, A. and Waithman, J. 2021. Fine-tuning the tumour microenvironment: Current perspectives on the mechanisms of tumour immunosuppression. Cells, 10(1): 56.
Blaise, G.A., Gauvin, D., Gangal, M. and Authier, S. 2005. Nitric oxide, cell signaling and cell death. Toxicology, 208(2): 177-192.
Boulanger, N. 2018. Skin and arthropod vectors. Academic Press.
Cakir, B.Ö., Adamson, P. and Cingi, C. 2012. Epidemiology and economic burden of nonmelanoma skin cancer. Facial plastic surgery clinics of North America, 20(4): 419-422.
Chill, H., Safrai, M., Reuveni Salzman, A. and Shushan, A. 2017. The rising phoenix-progesterone as the main target of the medical therapy for leiomyoma. BioMed research international, 2017.
Choudhari, S.K., Chaudhary, M., Bagde, S., Gadbail, A.R. and Joshi, V. 2013. Nitric oxide and cancer: A review. World journal of surgical oncology, 11(1): 1-11.
Delker, S.L., Xue, F., Li, H., Jamal, J., Silverman, R.B. and Poulos, T.L. 2010. Role of zinc in isoform-selective inhibitor binding to neuronal nitric oxide synthase. Biochemistry, 49(51): 10803-10810.
Dimitrakakis, C., Zava, D., Marinopoulos, S., Tsigginou, A., Antsaklis, A. and Glaser, R. 2010. Low salivary testosterone levels in patients with breast cancer. BMC cancer, 10(1): 1-8.
Funder, J.W., Krozowski, Z., Myles, K., Sato, A., Sheppard, K.E. and Young, M. 1997. Mineralocorticoid receptors, salt, and hypertension. Recent progress in hormone research, 52: 247-260; discussion 261.
Heijmans, J., Muncan, V., Jacobs, R.J., de Jonge-Muller, E.S., Graven, L., Biemond, I., Ederveen, A.G., Groothuis, P.G., Mosselman, S. and Hardwick, J.C. 2011. Intestinal tumorigenesis is not affected by progesterone signaling in rodent models. PLoS One, 6(7): e22620.
Khorram, O. and Han, G. 2009. Influence of progesterone on endometrial nitric oxide synthase expression. Fertility and sterility, 91(5): 2157-2162.
Kolovou, G., Ragia, G., Kolovou, V., Mihas, C., Katsiki, N., Vasiliadis, I., Mavrogeni, S., Vartela, V., Tavridou, A. and Manolopoulos, V.G. 2014. Impact of cyp3a5 gene polymorphism on efficacy of simvastatin. The open cardiovascular medicine journal, 8: 12.
Li, X. and O'Malley, B.W. 2003. Unfolding the action of progesterone receptors. Journal of biological chemistry, 278(41): 39261-39264.
Liu, Y. and Feng, Q. 2012. Noing the heart: Role of nitric oxide synthase-3 in heart development. Differentiation, 84(1): 54-61.
Meier, P., Finch, A. and Evan, G. 2000. Apoptosis in development. Nature, 407(6805): 796-801.
Mohsenpour, K., Hekmat, A., Atyabi, S.M. and Bakhshandeh, H. 2021. Nanoscale, 8(1): 132-148.
Richards, G., Klimek, M., Jasienska, G. and Marcinkowska, U.M. 2018. Digit ratio (2d: 4d) and circulating testosterone, oestradiol, and progesterone levels across the menstrual cycle. Early human development, 117: 68-73.
Schini-Kerth, V.B., Auger, C., Kim, J.-H., Étienne-Selloum, N. and Chataigneau, T. 2010. Nutritional improvement of the endothelial control of vascular tone by polyphenols: Role of no and edhf. Pflügers Archiv-European Journal of Physiology, 459(6): 853-862.
Shutze, W.P. and Patman, R.D. 1995. Nonatherosclerotic vascular diseases and vasospastic conditions: Inflammatory conditions (part 1 of a 3-part series). In: Baylor University Medical Center Proceedings. Taylor & Francis: pp: 21-28.
Sudhakar, A. 2009. History of cancer, ancient and modern treatment methods. Journal of cancer science & therapy, 1(2): 1.
Taguchi, K., Morishige, A., Matsumoto, T., Kamata, K. and Kobayashi, T. 2012. Enhanced estradiol-induced vasorelaxation in aortas from type 2 diabetic mice may reflect a compensatory role of p38 mapk-mediated enos activation. Pflügers Archiv-European Journal of Physiology, 464(2): 205-215.
Verzola, D., Gandolfo, M.T., Salvatore, F., Villaggio, B., Gianiorio, F., Traverso, P., Deferrari, G. and Garibotto, G. 2004. Testosterone promotes apoptotic damage in human renal tubular cells. Kidney international, 65: 252–1261.